ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$263.52
Tradestie Score
47
Market Cap
$12.36B
P/E Ratio
20.8
Revenue Growth
1.1%
Analyst Upside
+19.5%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$32.47
|
$19.56B | 26.2 | 41 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.47
|
$16.93B | 15.9 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.61
|
$15.70B | 32.6 | 52 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$17.55
|
$15.22B | - | 41 | Compare |
|
EXEL
Exelixis Inc
|
$56.12
|
$11.09B | 18.3 | 41 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$40.82
|
$10.76B | - | 39 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$143.97
|
$10.74B | - | 39 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$65.68
|
$10.53B | 174.1 | 58 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.21
|
$10.49B | - | 50 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$72.44
|
$10.22B | - | 57 | Compare |
More ASND Analysis
Data updated: Sep 11, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry